Call for Abstract

25th International Congress on Pharmaceutical Biotechnology, will be organized around the theme “To Explore the Future of Medicine in Pharmaceutical Biotechnology”

Euro Pharmaceutical Biotechnology 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Euro Pharmaceutical Biotechnology 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 2-1Biomedical Data Engineering
  • Track 2-2Bioinformatics Engineering
  • Track 2-3Industrial Pharma Biotechnology
  • Track 2-4Genetic Engineering and Tissue Engineering
  • Track 3-1Applications of Computation in Biologic Drug Development
  • Track 3-2Physics-based molecular modelling
  • Track 3-3Protein sequence-structural contexts and degradation reaction mechanisms
  • Track 3-4Pre-clinical immunogenicity risk assessment of bio therapeutics
  • Track 4-1To develop useful and beneficial plants
  • Track 4-2Process of traditional plant breeding
  • Track 4-3Applications of environmental management
  • Track 4-4Applications of agriculture
  • Track 4-5Improvement of agricultural production
  • Track 5-1Drug Safety
  • Track 5-2Adverse Drug Reaction
  • Track 5-3Pharmacovigilance and Risk Management
  • Track 5-4Pharmacovigilance Significance and Scope
  • Track 6-1Molecular biotechnology
  • Track 6-2Techniques of biotech Pharma
  • Track 6-3Engineering Machineries
  • Track 6-4New biotech Pharma drug design
  • Track 7-1Protein Interactions
  • Track 7-2Herbal Drug Interactions
  • Track 7-3Nanoparticle drugs
  • Track 7-4Pharmacogenomics
  • Track 7-5Bioinformatics
  • Track 8-1Pre -Clinical Studies
  • Track 8-2Regulatory Update
  • Track 8-3Clinical Design
  • Track 8-4Upcoming Challenges in Clinical Trails
  • Track 9-1Chemical disinfectant testing
  • Track 9-2Cleaning studies
  • Track 9-3Particulate testing of chemicals
  • Track 9-4Sampling and analysis of solvents
  • Track 9-5Biotechnology in chemical industry
  • Track 9-6Biofuels in chemical industry
  • Track 9-7Controlled drug delivery
  • Track 9-8Mechanisms of Action and Toxicity
  • Track 9-9Factors Affecting Drug Metabolism
  • Track 10-1Tissue biomaterials
  • Track 10-2Pharmaceutical engineering
  • Track 10-3Drug Elimination and Clearance
  • Track 10-4Pharmacogenomics
  • Track 10-5Biomaterials
  • Track 10-6Pronuclear Microinjection Method
  • Track 10-7Bioinformatics
  • Track 11-1Biochemical tools for investigating
  • Track 11-2Engineering applied to the biosciences
  • Track 11-3Biosynthetic products structure modification
  • Track 11-4Formulation of biotech products
  • Track 11-5Screening and synthesis of Nano drug design
  • Track 11-6Biodegradable microspheres
  • Track 12-1Biopharma Regulatory challenges
  • Track 12-2Regulatory Approvals for Biopharma drug products
  • Track 12-3Overview of drug, biologic and device regulatory pathways
  • Track 12-4Role of Regulatory Authorities
  • Track 12-5BPCI Act
  • Track 12-6Hatch-Waxman Act
  • Track 13-1Pharmacogenomics Drugs
  • Track 13-2Biological products Used in Drug Discovery
  • Track 13-3Human Genomic Project
  • Track 13-4Cell based Therapies
  • Track 14-1Novel Approaches to Analytical and Bio analytical Methods
  • Track 14-2Bio analytical Techniques
  • Track 14-3Chromatography Techniques
  • Track 14-4Spectroscopic Techniques
  • Track 14-5Nuclear Magnetic Resonance
  • Track 14-6Mass Spectroscopy
  • Track 14-7Regulatory Issues and Biosafety Challenges in Bio analysis
  • Track 14-8Applications of Analytical and Bio analytical Methods
  • Track 15-1Green Technology
  • Track 15-2Biotechnology and Diabetes
  • Track 15-3Food and industrial biotechnology
  • Track 15-4Biomedical engineering
  • Track 15-5Medical biotechnology
  • Track 15-6Medical biotechnology Biotech Pharma quality issues
  • Track 16-1Stem cell biotechnology
  • Track 16-2Prokaryotic cells in biotech production
  • Track 16-3Microbial origin
  • Track 16-4Fermentation process
  • Track 16-5Pharmacokinetics and pharmacodynamics
  • Track 17-1Culture manipulation of biological products
  • Track 17-2Regulatory issues and drug approval
  • Track 17-3Biotech drug design
  • Track 17-4Evaluation studies
  • Track 17-5Chromatography techniques
  • Track 18-1Modern biotech market analysis
  • Track 18-2Economic considerations in medical
  • Track 18-3Products supply statistics
  • Track 18-4Market research reports & industry analysis
  • Track 18-5Companion technologies and markets
  • Track 18-6Regulatory Aspects